Skip to main content
Mark Ahlman, MD, Nuclear Medicine, Augusta, GA

MarkAllanAhlmanMD

Nuclear Medicine Augusta, GA

Physician

Dr. Ahlman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ahlman's full profile

Already have an account?

  • Office

    1120 15th St
    Augusta, GA 30912
    Phone+1 706-721-8623
    Fax+1 706-721-1459

Education & Training

  • Medical University of South Carolina
    Medical University of South CarolinaResidency, Nuclear Medicine, 2009 - 2012
  • Medical University of South Carolina College of Medicine
    Medical University of South Carolina College of MedicineInternship, Transitional Year, 2008 - 2009
  • Medical College of Georgia at Augusta University
    Medical College of Georgia at Augusta UniversityClass of 2008

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2022 - 2026
  • MD State Medical License
    MD State Medical License 2012 - 2026
  • SC State Medical License
    SC State Medical License 2008 - 2012
  • American Board of Nuclear Medicine Nuclear Medicine

Publications & Presentations

PubMed

Abstracts/Posters

  • Phase 2 Study of Alemtuzumab Added to Dose-Adjusted EPOCH-R in Relapsed and Refractory Aggressive B-Cell Lymphomas
    Mark A. Ahlman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Response-Adapted Therapy in HIV-Associated Diffuse Large B-Cell Lymphoma: Updated Results of a Prospective Phase II Study of Short-Course-EPOCH-RR
    Mark A. Ahlman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • FAPI-PET Can Visualize Changes in Joints of Rheumatoid Arthritis Patients: Study
    FAPI-PET Can Visualize Changes in Joints of Rheumatoid Arthritis Patients: StudyMarch 17th, 2023
  • The Challenges of and New Horizons in Takayasu Arteritis Imaging
    The Challenges of and New Horizons in Takayasu Arteritis ImagingJune 12th, 2022